论文部分内容阅读
为了评价肝动脉化疗灌注（ＨＡＩ）结合外放射对不适宜做动脉栓塞（ＴＡＥ）治疗的肝癌患者的疗效。采用ＨＡＩ结合外放射的方法治疗不适宜做ＴＡＥ治疗的原发性大肝癌３０例。总有效率（ＣＲ＋ＰＲ）４０．０％，１，３，５ａ生存率分别为５８．４％，２０．２％，７．８％，平均生存期１３．６个月。多数病例能耐受治疗，但３例ＣｈｉｌｄＣ级病例中，有２例死于因治疗所致的肝功能衰竭。结果提示ＨＡＩ结合外放射是治疗不适宜行ＴＡＥ的大肝癌的有效方法，但不适于ＣｈｉｌｄＣ级患者。
To evaluate the efficacy of hepatic arterial chemoembolization (HAI) combined with external radiation in patients with hepatocellular carcinoma who are not eligible for arterial embolization (TAE). HAI combined with external radiation was used to treat 30 cases of primary hepatocellular carcinoma that were not suitable for TAE treatment. The total effective rate (CR+PR) was 40.0%, and the 1,3,5a survival rates were 58.4%, 20.2%, and 7.8%, respectively. The average survival time was 13.6 months. Most cases were able to tolerate treatment, but in 3 ChildC-grade cases, 2 cases died of hepatic failure due to treatment. The results suggest that HAI combined with external radiation is an effective method for treating large hepatocellular carcinoma that is not suitable for TAE, but it is not suitable for ChildC-class patients.